| Historiographs |
Grand Totals: LCS 41775, GCS 99687 Collection span: 1970 - 2007 | |
| Title Word List (4902) Word count: 33598, All words count: 48690 | ||
| # | Word | Recs | TLCS | TGCS |
|---|---|---|---|---|
| 201 | PROPENSITY | 15 | 279 | 581 |
| 202 | RADIOIMMUNOASSAY | 12 | 277 | 902 |
| 203 | MODEL | 35 | 273 | 766 |
| 204 | ATENOLOL | 8 | 272 | 410 |
| 205 | CONCENTRATION | 16 | 271 | 490 |
| 206 | DARK | 44 | 269 | 646 |
| 207 | DARKNESS | 23 | 269 | 476 |
| 208 | CHEMICAL | 25 | 266 | 926 |
| 209 | REPLACEMENT | 14 | 266 | 412 |
| 210 | CHRONOBIOLOGIC | 7 | 265 | 274 |
| 211 | MEDIATED | 18 | 264 | 720 |
| 212 | SEASON | 23 | 264 | 621 |
| 213 | SULFATOXYMELATONIN | 16 | 264 | 416 |
| 214 | TOTALLY | 8 | 264 | 266 |
| 215 | CONTROLS | 28 | 261 | 456 |
| 216 | INTERACTIONS | 17 | 259 | 1534 |
| 217 | CONSTANT | 26 | 257 | 446 |
| 218 | IMPLICATIONS | 51 | 256 | 970 |
| 219 | ABNORMALITIES | 13 | 254 | 427 |
| 220 | HIGH | 32 | 253 | 414 |
| 221 | BREAST | 27 | 252 | 1267 |
| 222 | NEW | 41 | 250 | 591 |
| 223 | VOLUNTEERS | 16 | 250 | 386 |
| 224 | SENSITIVITY | 38 | 246 | 689 |
| 225 | INSOMNIACS | 8 | 245 | 373 |
| 226 | POSSIBLE | 34 | 245 | 612 |
| 227 | HOURS | 12 | 243 | 327 |
| 228 | MENTAL | 23 | 243 | 559 |
| 229 | HEALTH | 37 | 242 | 666 |
| 230 | LONG | 33 | 241 | 653 |
| # | Word | Recs | TLCS | TGCS |
| 231 | FOLLOWING | 30 | 238 | 482 |
| 232 | TELEPHONE | 2 | 235 | 320 |
| 233 | COUNTY | 2 | 234 | 316 |
| 234 | DAILY | 33 | 234 | 690 |
| 235 | MARYLAND | 1 | 234 | 314 |
| 236 | MONTGOMERY | 1 | 234 | 314 |
| 237 | POSITION | 6 | 233 | 256 |
| 238 | TRYPTOPHAN | 25 | 233 | 819 |
| 239 | EXOGENOUS | 28 | 231 | 467 |
| 240 | QUALITY | 25 | 231 | 531 |
| 241 | EYE | 30 | 230 | 556 |
| 242 | WHITE | 18 | 225 | 281 |
| 243 | DEPRIVATION | 37 | 224 | 628 |
| 244 | PROMOTING | 7 | 224 | 430 |
| 245 | RESULTS | 21 | 221 | 413 |
| 246 | VALIDATION | 9 | 219 | 554 |
| 247 | TREAT | 7 | 218 | 365 |
| 248 | ALZHEIMER | 24 | 215 | 751 |
| 249 | NOVEL | 17 | 215 | 868 |
| 250 | REST | 21 | 215 | 589 |
| 251 | DECREASES | 7 | 214 | 261 |
| 252 | DIRECT | 13 | 214 | 780 |
| 253 | EARLY | 30 | 214 | 625 |
| 254 | NUCLEUS | 37 | 214 | 1322 |
| 255 | DIFFERENCES | 20 | 213 | 514 |
| 256 | SULFATE | 8 | 213 | 414 |
| 257 | EXPERIMENTAL | 21 | 212 | 420 |
| 258 | LATITUDES | 3 | 211 | 258 |
| 259 | SAD | 38 | 211 | 294 |
| 260 | BIOLOGICAL | 57 | 210 | 867 |
| # | Word | Recs | TLCS | TGCS |
| 261 | CRITICAL | 15 | 210 | 378 |
| 262 | TERM | 30 | 210 | 548 |
| 263 | HAMSTER | 33 | 209 | 848 |
| 264 | LATE | 15 | 209 | 336 |
| 265 | IMPROVES | 14 | 208 | 433 |
| 266 | SENSITIVE | 8 | 208 | 360 |
| 267 | SYRIAN | 22 | 207 | 902 |
| 268 | SUPERSENSITIVITY | 7 | 206 | 245 |
| 269 | FACTORS | 30 | 204 | 1008 |
| 270 | SINGLE | 23 | 203 | 332 |
| 271 | CELL | 13 | 202 | 1493 |
| 272 | DEMENTIA | 16 | 202 | 688 |
| 273 | EXERCISE | 26 | 200 | 488 |
| 274 | POTENTIAL | 19 | 200 | 466 |
| 275 | MALE | 42 | 199 | 630 |
| 276 | SHORT | 36 | 199 | 498 |
| 277 | BEHAVIORAL | 41 | 197 | 1014 |
| 278 | NATURAL | 18 | 197 | 317 |
| 279 | ADULTS | 23 | 195 | 462 |
| 280 | EVALUATION | 22 | 195 | 400 |
| 281 | MAINTENANCE | 14 | 195 | 340 |
| 282 | BETA | 41 | 193 | 1025 |
| 283 | BIOLOGY | 7 | 193 | 1257 |
| 284 | CIRCULATING | 11 | 192 | 895 |
| 285 | INCIDENCE | 10 | 192 | 284 |
| 286 | DRUGS | 21 | 187 | 820 |
| 287 | FUNCTIONAL | 21 | 187 | 925 |
| 288 | MAY | 11 | 187 | 284 |
| 289 | SPECTRUM | 11 | 187 | 429 |
| 290 | PHYSIOLOGY | 24 | 186 | 764 |
| # | Word | Recs | TLCS | TGCS |
| 291 | RECEPTORS | 32 | 186 | 989 |
| 292 | DURATION | 19 | 185 | 456 |
| 293 | HISTORY | 13 | 184 | 240 |
| 294 | INDIVIDUALS | 15 | 183 | 362 |
| 295 | SLEEPINESS | 25 | 182 | 476 |
| 296 | STABILITY | 7 | 182 | 388 |
| 297 | URINE | 9 | 181 | 336 |
| 298 | MALADAPTATION | 3 | 180 | 295 |
| 299 | SULPHATOXYMELATONIN | 21 | 179 | 341 |
| 300 | REDUCES | 12 | 178 | 299 |
| 301 | MOLECULAR | 18 | 175 | 720 |
| 302 | AFFECTS | 11 | 174 | 262 |
| 303 | MULTICENTER | 7 | 173 | 251 |
| 304 | CURRENT | 17 | 172 | 353 |
| 305 | MOUSE | 26 | 172 | 511 |
| 306 | SALIVA | 12 | 172 | 263 |
| 307 | DRUG | 26 | 171 | 936 |
| 308 | PHOTORECEPTOR | 5 | 171 | 332 |
| 309 | LITERATURE | 11 | 170 | 324 |
| 310 | NIGHTTIME | 18 | 170 | 332 |
| 311 | SAMPLE | 14 | 170 | 260 |
| 312 | CONDITIONS | 23 | 169 | 466 |
| 313 | DUSK | 7 | 169 | 279 |
| 314 | GATE | 6 | 169 | 223 |
| 315 | ALZHEIMERS | 5 | 167 | 410 |
| 316 | ASSOCIATED | 37 | 167 | 440 |
| 317 | FLIGHT | 14 | 167 | 218 |
| 318 | SLOW | 12 | 167 | 600 |
| 319 | ILLUMINATION | 15 | 166 | 303 |
| 320 | SECRETORY | 6 | 166 | 228 |
| # | Word | Recs | TLCS | TGCS |
| 321 | SUBSYNDROMAL | 10 | 166 | 212 |
| 322 | MEASURES | 6 | 165 | 281 |
| 323 | PITUITARY | 28 | 165 | 709 |
| 324 | DEVELOPMENT | 34 | 164 | 673 |
| 325 | NERVOSA | 16 | 163 | 284 |
| 326 | SUPER | 2 | 160 | 166 |
| 327 | LITHIUM | 42 | 159 | 430 |
| 328 | DELAY | 16 | 158 | 239 |
| 329 | CORRELATION | 15 | 157 | 400 |
| 330 | IMPROVE | 8 | 156 | 208 |
| 331 | SALIVARY | 12 | 156 | 275 |
| 332 | SCHEDULE | 21 | 154 | 310 |
| 333 | STRUCTURE | 11 | 154 | 497 |
| 334 | ASSOCIATION | 22 | 153 | 443 |
| 335 | PHYSIOLOGIC | 1 | 152 | 255 |
| 336 | SIMULATION | 14 | 152 | 207 |
| 337 | TWO | 16 | 152 | 439 |
| 338 | IRRADIANCE | 5 | 151 | 215 |
| 339 | MECHANISM | 15 | 151 | 501 |
| 340 | RHYTHMICITY | 15 | 151 | 396 |
| 341 | INCREASES | 26 | 150 | 506 |
| 342 | PSYCHIATRY | 19 | 149 | 401 |
| 343 | RELATIONSHIPS | 14 | 149 | 419 |
| 344 | SCHEDULED | 6 | 149 | 181 |
| 345 | SOCIAL | 23 | 148 | 558 |
| 346 | IMPROVEMENT | 7 | 147 | 258 |
| 347 | BLINDNESS | 10 | 146 | 230 |
| 348 | HYPNOTIC | 10 | 146 | 274 |
| 349 | METABOLISM | 27 | 146 | 831 |
| 350 | ROUTINE | 11 | 146 | 199 |
| # | Word | Recs | TLCS | TGCS |
| 351 | PSYCHIATRIC | 31 | 145 | 912 |
| 352 | REPRODUCTION | 8 | 145 | 742 |
| 353 | REPRODUCTIVE | 10 | 145 | 751 |
| 354 | ENDOCRINE | 21 | 144 | 614 |
| 355 | ENHANCEMENT | 6 | 144 | 394 |
| 356 | INFLUENCES | 22 | 144 | 556 |
| 357 | CHARACTERISTICS | 16 | 143 | 281 |
| 358 | CHARACTERIZATION | 12 | 143 | 899 |
| 359 | DISTURBED | 11 | 143 | 248 |
| 360 | HORMONAL | 19 | 143 | 523 |
| 361 | PUBERTY | 10 | 143 | 455 |
| 362 | SWITZERLAND | 2 | 143 | 151 |
| 363 | DIFFERENTIAL | 22 | 142 | 520 |
| 364 | INHIBITION | 19 | 142 | 730 |
| 365 | TRAIT | 2 | 142 | 149 |
| 366 | PROFILE | 12 | 141 | 202 |
| 367 | REDUCED | 9 | 141 | 364 |
| 368 | TRANSDUCTION | 8 | 141 | 477 |
| 369 | ALASKA | 3 | 140 | 152 |
| 370 | TEMPORAL | 13 | 140 | 436 |
| 371 | TEST | 18 | 140 | 250 |
| 372 | DESYNCHRONY | 6 | 139 | 221 |
| 373 | NORWAY | 8 | 139 | 186 |
| 374 | ADOLESCENTS | 16 | 138 | 290 |
| 375 | SEX | 10 | 137 | 356 |
| 376 | DEPLETION | 12 | 136 | 323 |
| 377 | RANDOMIZED | 16 | 136 | 290 |
| 378 | GENE | 32 | 134 | 555 |
| 379 | BRIEF | 9 | 133 | 255 |
| 380 | ELECTROENCEPHALOGRAPHIC | 4 | 133 | 474 |
| # | Word | Recs | TLCS | TGCS |
| 381 | FATIGUE | 27 | 133 | 457 |
| 382 | INVITRO | 11 | 133 | 431 |
| 383 | ABOLISHES | 2 | 132 | 137 |
| 384 | CONTRIBUTION | 6 | 132 | 517 |
| 385 | MANIA | 14 | 132 | 267 |
| 386 | PRIMARY | 21 | 132 | 286 |
| 387 | REGULATOR | 3 | 132 | 218 |
| 388 | RISK | 16 | 131 | 641 |
| 389 | AGONIST | 24 | 130 | 461 |
| 390 | ALTERATIONS | 15 | 130 | 598 |
| 391 | BULIMIA | 13 | 130 | 291 |
| 392 | CHANGE | 11 | 130 | 268 |
| 393 | CHRONOBIOTIC | 11 | 130 | 220 |
| 394 | COORDINATING | 1 | 130 | 530 |
| 395 | ACTIONS | 10 | 129 | 421 |
| 396 | INDUCES | 6 | 129 | 242 |
| 397 | OCULAR | 14 | 129 | 395 |
| 398 | ONE | 10 | 129 | 169 |
| 399 | PERSONALITY | 23 | 129 | 230 |
| 400 | PHARMACOLOGICAL | 30 | 129 | 728 |